{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:25Z","timestamp":1767151165701,"version":"build-2238731810"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,4,12]]},"DOI":"10.1038\/s41416-021-01281-5","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T12:53:28Z","timestamp":1613566408000},"page":"1463-1464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reply to \u201cComment on: Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project\u201d"],"prefix":"10.1038","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-8705","authenticated-orcid":false,"given":"Abeer M.","family":"Shaaban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-8910","authenticated-orcid":false,"given":"Sarah E.","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"1281_CR1","unstructured":"Van Bockstal, M. R. Libbrecht, L. Galanta, C. Comment on: Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project. Br. J. Cancer."},{"key":"1281_CR2","doi-asserted-by":"publisher","unstructured":"Shaaban, A. M., Hilton, B., Clements, K., Provenzano, E., Cheung, S., Wallis, M. G. et al. Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project. Br. J. Cancer. https:\/\/doi.org\/10.1038\/s41416-020-01152-5 (2020).","DOI":"10.1038\/s41416-020-01152-5"},{"key":"1281_CR3","doi-asserted-by":"crossref","unstructured":"Shah, V., Megalios, A., Shami, R., Sridharan, M., Salinas de Souza, C., Kumar, T. et al. Genomic analysis of paired DCIS and subsequent recurrence to assess clonal relatedness in screen detected DCIS [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium. 2019; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P4-07-04.","DOI":"10.1158\/1538-7445.SABCS19-P4-07-04"},{"key":"1281_CR4","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders, M. E., Schuyler, P. A., Dupont, W. D. & Page, D. L. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103, 2481\u20132484 (2005).","journal-title":"Cancer"},{"key":"1281_CR5","doi-asserted-by":"crossref","unstructured":"Stout, N. K., Cronin, A. M., Uno, H., Ozanne, E. M., Hassett, M. J., Frank, E. S. et al. Estrogen-receptor status and risk of contralateral breast cancer following DCIS. Breast Cancer Res. Treatment 171, 777\u2013781 (2018).","DOI":"10.1007\/s10549-018-4860-5"}],"updated-by":[{"DOI":"10.1038\/s41416-021-01520-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000}}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01281-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01281-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01281-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:13:24Z","timestamp":1649164404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01281-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,4,12]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1038\/s41416-021-01281-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"29 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41416-021-01520-9","URL":"https:\/\/doi.org\/10.1038\/s41416-021-01520-9","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics Committee approval was not required for this study, originally conducted under the NHS Cancer Screening Programme\u2019s application to the Patient Information Advisory Group (PIAG). More recently, the study has been permitted to process personally identifiable data without consent under Regulation 5 of Statutory Instrument 2002 No. 1438: The Health Service (Control of Patient Information) Regulations 2002 (15\/CAG\/0207) in line with the following clause: \u201cquality assuring screening services to ensure they are effective and safe, and that any incidents are investigated and managed appropriately\u201d. This statutory exemption to common law permits Public Health England to process personally identifiable data for activities it is \u2018responsible and accountable to the Secretary of State for Health for\u2019, as part of its core remit for population screening.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Data is held by Public Health England. Access to the Sloane Project data from external parties is governed by consultation with the Sloane Project Steering Group and application to Public Health England\u2019s breast screening research advisory committee (RAC) and Public Health England\u2019s office for data release (ODR). Data will subsequently only be released by Public Health England to researchers under approval and in an anonymised or depersonalised format, with a data sharing contract in place.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Sloane Project was supported by Public Health England and, in part, by Cancer Research UK and by KWF Kankerbestrijding (ref. C38317\/A24043).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}